Tyrosine kinases in inflammatory dermatologic disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine kinases in inflammatory dermatologic disease

Published:2011-08 Issue:2 Volume:65 Page:389-403
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Paniagua Ricardo T.,Fiorentino David F.,Chung Lorinda,Robinson William H.

Funder

National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases

Department of Veterans Affairs

Scleroderma Research Foundation

Publisher

Elsevier BV

Subject

Dermatology

Reference157 articles.

1. Reversal of experimental pulmonary hypertension by PDGF inhibition;Schermuly;J Clin Invest,2005

2. Imatinib for the treatment of pulmonary arterial hypertension;Ghofrani;N Engl J Med,2005

3. Targeting Syk as a treatment for allergic and autoimmune disorders;Wong;Expert Opin Investig Drugs,2004

4. Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice;Louvet;Proc Natl Acad Sci U S A,2008

5. Tyrosine kinases as targets for the treatment of rheumatoid arthritis;D'Aura Swanson;Nat Rev Rheumatol,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis;Annals of Pharmacotherapy;2023-06-21

2. Tyrosine kinases in the pathogenesis of tissue fibrosis in systemic sclerosis and potential therapeutic role of their inhibition;Translational Research;2021-05

3. Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study;Frontiers in Medicine;2021-02-03

4. Flotillin and AP2A1/2 Promote IGF-1 Receptor Association with Clathrin and Internalization in Primary Human Keratinocytes;Journal of Investigative Dermatology;2020-09

5. Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis;Biomedicine & Pharmacotherapy;2019-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3